Dr. Harold is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
309 Rutherford Street
Apt A
Greenville, SC 29609
Education & Training
- Medical College of Wisconsin Affiliated HospitalsResidency, Obstetrics and Gynecology, 2016 - 2020
- University of South Carolina School of Medicine GreenvilleClass of 2016
Certifications & Licensure
- SC State Medical License 2023 - 2025
- CT State Medical License 2020 - 2024
- WI State Medical License 2017 - 2021
- NC State Medical License 2018 - 2018
Publications & Presentations
PubMed
- 28 citationsA phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated charact...Stefania Bellone, Dana M. Roque, Eric R. Siegel, Natalia Buza, Pei Hui
Annals of Oncology. 2021-04-28 - 6 citationsElimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma.Justin Harold, Stefania Bellone, Diego D Manavella, Levent Mutlu, Blair McNamara
Gynecologic Oncology. 2023-01-01 - 3 citationsOvarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor.Diego D Manavella, Blair McNamara, Justin Harold, Stefania Bellone, Tobias Max Philipp Hartwich
Gynecologic Oncology. 2023-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: